产品分类
Product Category详细介绍
| 品牌 | absin | CAS | 4008-48-4 |
|---|---|---|---|
| 分子式 | C9H6N2O3 | 纯度 | >98% |
| 分子量 | 190.16 | 货号 | abs47027047 |
| 规格 | 20mg | 供货周期 | 现货 |
| 主要用途 | is a fluorquinolone that is active agai | 应用领域 | 化工,生物产业,农林牧渔,制药/生物制药,综合 |
Nitroxoline 4008-48-4
| 产品描述 | |
| 描述 | Nitroxoline is a urinary antibacterial agent active against susceptible gram-positive and gram-negative organisms commonly found in urinary tract infections. It is a fluorquinolone that is active against bacterial gyrases. |
| 纯度 | >98% |
| 储存/保存方法 | Store at -20℃ for one year(Powder);Store at 2-4℃ for two weeks;Store at -20℃ for six months after dissolution. |
| 基本信息 | |
| 别名 | 硝羟喹啉;5-硝基-8-羟基喹啉;8-Hydroxy-5-nitroquinoline;5-Nitro-8-quinolinol |
| 外观 | 桔黄色至褐黄色结晶粉末 |
| 可溶性/溶解性 | DMSO : 36 mg/mL (189.3 mM) |
| 生物活性 | |
| 靶点 | cathepsin B |
| In vitro(体外研究) | Nitroxoline significantly reduces extracellular DQ-collagen IV degradation by all evaluated cancer cell lines using spectrofluorimetry. Nitroxoline also markedly decreases tumor cell invasion monitored in real time and reduces the invasive growth of multicellular tumor spheroids, used as a 3D in vitromodel of tumor invasion. Endothelial tube formation is significantly reduced by nitroxoline in an in vitro angiogenesis assay. |
| In vivo(体内研究) | Nitroxoline significantly abrogates tumor growth, angiogenesis and metastasis in vivo in LPB fibrosarcoma and MMTV-PyMT breast cancer mouse models. |
| 参考文献 | |
| 参考文献 |
|
| 研究领域 | |
| 研究领域 | CancerCancer Metabolism CancerTumor immunology MetabolismTypes of disease Drug DiscoverySmall Molecule DrugLead Compound Discovery |
产品咨询